TLDR Barclays upgraded Nike (NKE) to overweight, raising its price target from $64 to $73 NKE stock is down roughly 25% over the past 12 months and near a 10-yearTLDR Barclays upgraded Nike (NKE) to overweight, raising its price target from $64 to $73 NKE stock is down roughly 25% over the past 12 months and near a 10-year

Nike (NKE) Stock Gets Barclays Upgrade as Wall Street Eyes a Market Bottom

2026/03/17 01:49
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Barclays upgraded Nike (NKE) to overweight, raising its price target from $64 to $73
  • NKE stock is down roughly 25% over the past 12 months and near a 10-year low
  • North America sales rose 9% in the most recent quarter, but net income fell 31% year-over-year
  • Nike reports Q3 FY2026 earnings on March 31, a key moment for any turnaround narrative
  • Barclays believes investor sentiment may have hit “peak skepticism”

Nike has had a rough ride. The stock is down about 25% over the past year and is hovering near a 10-year low — a painful place for one of the most recognizable brands on the planet.


NKE Stock Card
NIKE, Inc., NKE

The company has been fighting on several fronts at once. Sales have been slow, competition from legacy and newer rivals is picking up, and a CEO change has added uncertainty on top of uncertainty. Throw in tariffs and cautious consumer spending, and you have a stock that’s hard to get excited about — at least until now.

On Monday, Barclays upgraded NKE to overweight and lifted its price target to $73, up from $64. The firm pointed to operational progress, improving financials, and more disciplined management as early signs that Nike is working its way out of the hole.

Barclays went a step further, suggesting the market may have reached “peak skepticism” on the stock — meaning things may not get worse from here.

North America Bright Spot, But Profits Still Hurting

The numbers tell a mixed story. In its most recent quarter, Nike’s North America segment posted 9% sales growth, and over the past six months, that market is up 6%. That’s a real positive.

But the bottom line hasn’t followed. Net income over the past two quarters came in at $1.5 billion, which is down 31% from a year ago. Rising costs are eating into whatever top-line progress the company is making.

That gap between revenue improvement and profit performance is what’s keeping a lot of investors on the sidelines.

Eyes on March 31

Nike’s next big test is its Q3 FY2026 earnings report, due March 31. The company will be reporting against weaker numbers from the same period last year, which could make year-over-year comparisons look better on paper.

Whether that translates into genuine momentum is the question. Some analysts think the setup could produce a beat. Others point to ongoing macro headwinds — consumers trading down to cheaper products, tariff pressure — as reasons to stay cautious.

The Barclays upgrade isn’t a blanket all-clear. The firm acknowledged Nike is not risk-free. But it does suggest that at current prices, the bad news may already be priced in.

The stock is currently trading near levels not seen in a decade. For some, that’s a warning sign. For others, it’s the setup for a recovery trade.

Nike reports earnings on March 31.

The post Nike (NKE) Stock Gets Barclays Upgrade as Wall Street Eyes a Market Bottom appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.